Mariner LLC Grows Stake in Doximity, Inc. (NASDAQ:DOCS)

Mariner LLC increased its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 27.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 31,309 shares of the company's stock after purchasing an additional 6,753 shares during the period. Mariner LLC's holdings in Doximity were worth $1,672,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. FMR LLC boosted its stake in shares of Doximity by 37.6% during the fourth quarter. FMR LLC now owns 9,409,313 shares of the company's stock valued at $502,363,000 after purchasing an additional 2,571,580 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in shares of Doximity by 708.7% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock valued at $80,641,000 after purchasing an additional 1,323,634 shares during the period. Invesco Ltd. boosted its stake in shares of Doximity by 525.1% during the fourth quarter. Invesco Ltd. now owns 1,272,403 shares of the company's stock valued at $67,934,000 after purchasing an additional 1,068,849 shares during the period. Franklin Resources Inc. boosted its stake in shares of Doximity by 1,178.3% during the fourth quarter. Franklin Resources Inc. now owns 1,062,211 shares of the company's stock valued at $56,711,000 after purchasing an additional 979,113 shares during the period. Finally, Lord Abbett & CO. LLC purchased a new stake in shares of Doximity during the third quarter valued at $29,453,000. Institutional investors own 87.19% of the company's stock.

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company's stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 37.40% of the stock is currently owned by corporate insiders.

Doximity Stock Performance

Shares of Doximity stock traded down $0.94 during trading on Wednesday, hitting $56.81. 1,525,764 shares of the company's stock were exchanged, compared to its average volume of 1,994,011. The business has a 50-day simple moving average of $59.64 and a 200-day simple moving average of $56.38. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21. The stock has a market capitalization of $10.61 billion, a price-to-earnings ratio of 56.81, a PEG ratio of 4.10 and a beta of 1.41.

Analyst Ratings Changes

DOCS has been the subject of several recent research reports. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and lifted their price objective for the company from $60.00 to $90.00 in a report on Friday, February 7th. Mizuho lifted their price objective on Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC lifted their price objective on Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a report on Friday, February 7th. The Goldman Sachs Group lifted their price objective on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, Raymond James reissued an "outperform" rating and set a $83.00 price target (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Doximity presently has a consensus rating of "Moderate Buy" and a consensus price target of $65.39.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.